Recorded on 20 Dec 2023šConvo with Matthew Bradbard, Managing Director, RCM China @TheDerivativebyRCMAlternatives, hosted by Alvin Fan, CEO, OP Investment Management (OPIM) (0:48) Why China, why now? (2:32) SMA vs funds (6:52) Untapped Chinese commodities (8:58) Achieving Sharpe ratios twice as high in China (12:06) Onshore partners for access and insights (16:54) Disclaimers RCM China's Matt opens up about their experience venturing into China's markets. They discuss backtesting systematic strategies on Chinese commodities, with some strategies achieving over double the Sharpe ratios of other regions. RCM also reflects on how collaborating locally with consultants and exchanges helped them gain valuable access and perspective. For any firm seeking to discover untapped alpha overseas, RCM's story of overcoming challenges to break into China's closed markets offers insightful lessons learned. OPIM - ā ā LinkedIn (OP Investment Management)ā ā // ā ā X (@opim_hk)ā ā // WeChat (hedgefund_club) // ā ā Website (www.opim.com.hk)ā FOR INFORMATIONAL PURPOSES ONLY This video shall not be published, circulated, reproduced or distributed or commercially exploited in any manner otherwise, in whole or in part, without the prior written consent of OPIM. Any trademarks, logos and related intellectual property rights in this video are either owned by OPIM or other third parties.Ā This video or any of its contents have not been reviewed by the SFC or any other regulatory body. All information is provided solely for informational purposes only and is neither to be taken as advice or recommendation for any specific investment product, strategy, plan, feature or other purpose in any jurisdiction, nor intended as an offer or solicitation of offer for purchase or sale of units of any funds, shares of securities or any financial instruments. This video or any of its contents do not constitute an endorsement, offer or solicitation of offer for purchase or sale of any financial instruments or services by OPIM.Ā All information including facts, opinions, projections and estimates based on the judgement of the author is provided āas isā and may be subject to change without notice. OPIM has no obligation to ensure such updates are brought to your attention. The information in this video has been prepared from sources OPIM believes to be reliable and without consideration of the objectives, financial situations or needs of any particular viewer. OPIM does not warrant the completeness, accuracy or reliability of any material or information and does not assume responsibility for any error of facts or opinions or for damages arising out of any personās reliance upon such material or information. You should make independent assessment of any legal, regulatory, tax, credit and accounting implications and consult with professional advisor(s) as you consider necessary regarding any information provided in this video.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Donāt Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
What it will take for AI to scale (energy, compute, talent)
10 Dec 2025
Azeem Azhar's Exponential View
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Beckerās Healthcare -- Spine and Orthopedic Podcast